Morgan Stanley Mereo Biopharma Group PLC Transaction History

Morgan Stanley

$1.27 Trillion
Q2 2024

A detailed history of Morgan Stanley transactions in Mereo Biopharma Group PLC stock. As of the latest transaction made, Morgan Stanley holds 207,736 shares of MREO stock, worth $860,027. This represents 0.0% of its overall portfolio holdings.

Number of Shares

207,736

Previous 1,382,689 84.98%

Holding current value

$860,027

Previous $4.56 Million 83.63%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.58 - $4.25 $3.03 Million - $4.99 Million	-1,174,953 Reduced 84.98%	207,736 $747,000
Q1 2024 Aug 16, 2024	BUY	$2.3 - $4.05 $3.01 Million - $5.29 Million	1,306,524 Added 1715.39%	1,382,689 $4.56 Million
Q1 2024 May 15, 2024	BUY	$2.3 - $4.05 $3.01 Million - $5.29 Million	1,306,524 Added 1715.39%	1,382,689 $4.56 Million
Q4 2023 Aug 16, 2024	SELL	$1.19 - $2.42 $156,569 - $318,401	-131,571 Reduced 63.34%	76,165 $175,000
Q4 2023 Feb 13, 2024	BUY	$1.19 - $2.42 $82,671 - $168,122	69,472 Added 1037.98%	76,165 $175,000
Q3 2023 Nov 15, 2023	SELL	$1.15 - $1.67 $2,674 - $3,884	-2,326 Reduced 25.79%	6,693 $8,000
Q1 2023 May 15, 2023	SELL	$0.71 - $1.22 $13,085 - $22,484	-18,430 Reduced 67.14%	9,019 $6,000
Q4 2022 Feb 14, 2023	SELL	$0.5 - $1.01 $60,821 - $122,858	-121,642 Reduced 81.59%	27,449 $20,000
Q3 2022 Nov 14, 2022	BUY	$0.82 - $1.73 $36,042 - $76,040	43,954 Added 41.81%	149,091 $129,000
Q2 2022 Oct 27, 2022	SELL	$0.33 - $1.69 $22,666 - $116,081	-68,687 Reduced 39.52%	105,137 $118,000
Q2 2022 Aug 15, 2022	SELL	$0.33 - $1.69 $22,666 - $116,081	-68,687 Reduced 39.52%	105,137 $118,000
Q1 2022 Oct 27, 2022	BUY	$1.04 - $1.7 $71,434 - $116,767	68,687 Added 65.33%	173,824 $195,000
Q1 2022 May 13, 2022	SELL	$1.04 - $1.7 $36,237 - $59,234	-34,844 Reduced 16.7%	173,824 $195,000
Q4 2021 Feb 14, 2022	BUY	$1.51 - $2.59 $283,164 - $485,692	187,526 Added 886.98%	208,668 $334,000
Q3 2021 Nov 15, 2021	BUY	$2.2 - $3.17 $46,512 - $67,020	21,142 New	21,142 $51,000

Others Institutions Holding MREO

# of Institutions

Shares Held

102M

Call Options Held

121K

Put Options Held

208K

View Full List

About Mereo Biopharma Group plc

Ticker MREO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,986,000
Market Cap $517M
Description
Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...

More about MREO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account